Institution statistics

PFIZER LIMITED - United Kingdom 

Ranking results:

Past rankings:
2019
Criterium:Position:
Overall Score:400-500
Total Number of Projects:200-300
2018
Criterium:Position:
Overall Score:800-900
Total Number of Projects:300-400
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2011
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
Ranking timeline:

European project participation (2010-01-01 - 2021-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 37
As coordinator: 0
As participant: 37
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 0 2.281.840 0 1
2020 0 78.198.006 0 6
2019 0 196.939.080 0 13
2018 0 103.838.674 0 7
2017 0 66.023.667 0 8
2016 0 14.080.000 0 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
NOVARTIS PHARMA25
JANSSEN PHARMACEUTICA NV19
UCB BIOPHARMA16
ELI LILLY AND COMPANY LIMITED15
F HOFFMANNLA ROCHE14
SANOFIAVENTIS13
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT11
BAYER10
KATHOLIEKE UNIVERSITEIT LEUVEN10
NOVO NORDISK10
TAKEDA DEVELOPMENT CENTRE EUROPE10
ABBVIE INC9
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG9
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD9
UNIVERSITY OF NEWCASTLE UPON TYNE9
ASTRAZENECA8
CHARITE UNIVERSITAETSMEDIZIN BERLIN8
MERCK SHARP & DOHME CORP8
UNIVERSITAIR MEDISCH CENTRUM UTRECHT8
BAYER AKTIENGESELLSCHAFT7
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM7
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE7
KAROLINSKA INSTITUTE7
SANOFIAVENTIS RECHERCHE & DEVELOPPEMENT7
ACADEMISCH ZIEKENHUIS GRONINGEN6
MEDIZINISCHE UNIVERSITAET WIEN6
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN6
STICHTING KATHOLIEKE UNIVERSITEIT6
STICHTING VUMC6
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL6
THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE6
THE UNIVERSITY OF MANCHESTER6
ASTRAZENECA AB5
EUROPEAN PATIENTS' FORUM5
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER5
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE5
LEIDS UNIVERSITAIR MEDISCH CENTRUM5
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN5
CHRISTIAN ALBRECHTS UNIVERSITAET ZU KIEL4
EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE4
FORUM DES PATIENTS EUROPEENS4
KING'S COLLEGE LONDON4
RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU4
SANOFIAVENTIS DEUTSCHLAND4
TEVA PHARMACEUTICAL INDUSTRIES LIMITED4
THE EUROPEAN INSTITUTE FOR INNOVATION THROUGH HEALTH DATA4
THE UNIVERSITY OF LIVERPOOL4
UNIVERSITY OF BIRMINGHAM4
UNIVERSITY OF BOLOGNA4
UNIVERSITY OF COPENHAGEN4
UNIVERSITY OF DUNDEE4
UPPSALA UNIVERSITET4
ACADEMIC MEDICAL CENTRE AMSTERDAM3
ACADEMISCH ZIEKENHUIS LEIDEN3
AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS3
ALLERGAN LIMITED3
AMGEN LIMITED3
ANTAROS MEDICAL AB3
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS3
AUSTRIAN RESEARCH CENTERS SIEBERDORF3
BRISTOLMYERS SQUIBB COMPANY CORP3
CELGENE MANAGEMENT SARL3
EBERHARD KARLS UNIVERSITAET TUEBINGEN3
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK3
EURICE EUROPEAN RESEARCH AND PROJECT OFFICE3
EUROPEAN CANCER PATIENT COALITION3
FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES3
FUJIFILM CELLULAR DYNAMICS INC3
FUNDACIO SANT JOAN DE DEU3
FUNDACION PARA EL FOMENTO DE LA INVESTIGACION SANITARIA Y BIOMEDICA DE LA COMUNITAT VALENCIANA3
GLAXOSMITHKLINE BIOLOGICALS3
GRUNENTHAL3
H LUNDBECK AS3
INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE3
INSTITUT DE RECHERCHES SERVIER3
IXSCIENT LIMITED3
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE3
OSPEDALE PEDIATRICO BAMBINO GESU3
SERVICIO ANDALUZ DE SALUD3
SERVICIO MADRILENO DE SALUD3
STATENS LEGEMIDDELVERK3
TAKEDA PHARMACEUTICALS INTERNATIONAL3
TARTU ULIKOOL3
THE SYNERGIST3
THE UNIVERSITY OF SHEFFIELD3
UNIVERSITA VITASALUTE SAN RAFFAELE3
UNIVERSITAET ZUERICH3
UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUSMAXIMILIANSUNIVERSITAT3
UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG UNIVERSITAET MAINZ3
UNIVERSITAT WIEN3
UNIVERSITATSKLINIKUM ERLANGEN3
UNIVERSITEIT GENT3
UNIVERSITY COLLEGE LONDON3
UNIVERSITY OF GLASGOW3
UNIVERSITY OF LEEDS3
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM2
BAYER PHARMA2
BIOMERIEUX2
CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE NANCY2
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS2
Constancy:

Total number of partners:1043

Partner loyalty:
Frequent Partner: (> 2 projects): 519
Rare Partner: 524

Frequent / Rare Partner Ratio: 0.99

Diversity:

Subjects:
Subject:No:
Diversity index:0
Categories:
Category:No:

Project overview:

Start dateProjectacronymrolefundingpartners
2021-01-01Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials SISAQOL-IMIparticipant2.281.84033
2020-11-01Gravitate–Health: Empowering and Equipping Europeans with health information for Active Personal Health Management and Adherence to Treatment Gravitate-Healthparticipant9.280.00040
2020-10-01H2O Health Outcomes Observatory H2Oparticipant10.476.68723
2020-10-01HEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES OFFENSIVE AGAINST NEOPLASMS IN HEMATOLOGY – PLUS HARMONY PLUSparticipant6.715.62539
2020-05-01EUbOPEN: Enabling and Unlocking biology in the OPEN EUbOPENparticipant27.935.00022
2020-01-01PharmaLedger PharmaLedgerparticipant8.290.69429
2020-01-01Better control and treatment of immune-mediated diseases by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsies ImmUniverseparticipant15.500.00026
2019-11-01EU Patient- cEntric clinicAl tRial pLatform EU-PEARLparticipant12.004.95336
2019-11-01Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases IDEA-FASTparticipant20.997.52346
2019-10-01Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies Immune-Imageparticipant15.000.00022
2019-09-01Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials Trials@Homeparticipant19.036.99831
2019-09-01Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions 3TRparticipant40.273.19270
2019-04-01Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement MOBILISE-Dparticipant25.395.89734
2019-04-01Biomarkers in Atopic Dermatitis and Psoriasis BIOMAPparticipant10.500.00032
2019-04-01Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation ConcePTIONparticipant15.299.99153
2019-03-01Neurotoxicity De-Risking in Preclinical Drug Discovery NeuroDeRiskparticipant5.331.00018
2019-03-01EBiSC2 – A sustainable European Bank for induced pluripotent Stem Cells EBiSC2participant4.599.64816
2019-02-01Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease TransBioLineparticipant13.999.99827
2019-01-01Investigating Mechanisms and Models Predictive of Accessibility of Therapeutics (IM2PACT) Into The Brain IM2PACTparticipant9.000.00027
2019-01-01Vaccines and Infectious Diseases in the Ageing PopuLation VITALparticipant5.499.88224
2018-11-01European Health Data and Evidence Network EHDENparticipant14.105.75022
2018-09-01Ensuring the future of EUPATI beyond 2020 EFOEUPATIparticipant365.24312
2018-09-01WEB-RADR 2 WEB-RADR 2participant1.168.75011
2018-07-01Research empowerment on solute carriers (ReSOLUTE) ReSOLUTEparticipant12.000.00014
2018-05-01conect4children (COllaborative Network for European Clinical Trials For Children) c4cparticipant67.000.00048
2018-05-01Integrated control and sensing platform for biopharmaceutical cultivation process high-throughput development and production iConsensusparticipant4.700.00019
2018-03-01Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes. PARADIGMparticipant4.498.93134
2017-11-01Combatting Bacterial Resistance in Europe - Clostridium Difficile Infections COMBACTE-CDIparticipant2.312.30514
2017-11-01Liver Investigation: Testing Marker Utility in Steatohepatitis LITMUSparticipant15.797.88156
2017-10-01European Quality In Preclinical Data EQIPDparticipant4.495.52330
2017-09-01Rheuma Tolerance for Cure RTCureparticipant6.000.00020
2017-02-01Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055 DO-ITparticipant3.549.83336
2017-01-01REspiratory Syncytial virus Consortium in EUrope - Sofia ref.: 116019 RESCEUparticipant14.498.12518
2017-01-01ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064 ITCC-P4participant7.370.00021
2017-01-01Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106 IB4SD-TRISTANparticipant12.000.00021
2016-10-01Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 PREFERparticipant6.000.00033
2016-04-01Psychiatric Ratings using Intermediate Stratified Markers - Sofia ref.: 115916 PRISMparticipant8.080.00023
Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum